Searchable abstracts of presentations at key conferences in endocrinology

ea0025p339 | Thyroid | SFEBES2011

Thyroid hormone receptor alpha is a permissive factor that regulates osteoclastogenesis indirectly

Nicholls Jonathan J , Combs Charlotte E , Williams Graham R , Bassett J H Duncan

Thyrotoxicosis is characterised by increased osteoclast activity. Thyroid hormone receptor alpha (TRα) is the predominant TR-isoform in bone and mice lacking TRα have skeletal hypothyroidism with impaired osteoclastic bone resorption. By contrast, mice lacking TRβ have skeletal hyperthyroidism and increased bone resorption. Thus, we hypothesized that T3 acts via TRα to stimulate osteoclastogenesis. Osteoclasts were differentiated in vitro ...

ea0022p375 | Endocrine Disruptors | ECE2010

Normal cortisol response to high dose Synacthen and insulin tolerance test in children and adults with Prader--Willi syndrome (PWS)

Farholt Stense , Sode-Carlsen Rasmus , Christiansen Jens Sandahl , Ostergaard John Rosendahl , Hoybye Charlotte

Objective: PWS is associated with hypogonadism and partial GH insufficiency. In addition partial insufficiency of the hypothalamic–pituitary–adrenal (HPA) axis recently was suggested (de Lind van Wijngaarden 2008) based upon an insufficient response to an overnight single-dose metyrapone in 15 out of 25 (60%) children. We aimed at further exploring this potentially dangerous condition.Methods: During a 1-year period genetically verified PWS pat...

ea0021p345 | Steroids | SFEBES2009

Dexamethasone testing and visceral:subcutaneous fat ratios in patients with adrenal incidentalomas

Debono Miguel , Hughes Tim , Durrington Charlotte , Williams Scott , Newell-Price John

Background: The Endocrine Society clinical practice guidelines suggest use of the 1 mg overnight dexamethasone suppression test (ONDST) to screen for cortisol excess in patients with adrenal incidentalomas, followed by the 48-h, 2 mg/day, low-dose dexamethasone-suppression test (LDDST), to confirm a positive result. Visceral fat accumulates in cortisol-excess and accounts for increased cardiovascular risk. In this study, we investigate whether the LDDST offers additional infor...

ea0016p233 | Diabetes and cardiovascular diseases | ECE2008

Quality of diabetes shared care in patients with diabetes type 2 in the diabetes clinic of Fredericia hospital

Sadauskiene Laima , Jorgensen Ulla Linding , Pedersen Jette , Moller Charlotte Chrois , Grodum Ellen , Gjessing Hans Jorgen

Aim: To evaluate the quality of diabetes group-based education followed by shared care. The diabetes education programme had a duration of 4 days and included screening for diabetes late complications. Patients with microvascular complications should visit the diabetes clinic four times a year. Patients without microvascular complications should visit their general practitioner every third month and the diabetes clinic once a year.Methods: Retrospective ...

ea0056p688 | Adrenal cortex (to include Cushing's) | ECE2018

Hair cortisol in adults with Prader-Willi syndrome

Shukur Hasanain , Rijke Yolanda de , Rossum Elisabeth van , Kampe Olle , Hoybye Charlotte

Background: Prader-Willi syndrome (PWS) is a rare genetic, neurodevelopmental disorder. In adults the syndrome is characterized by muscular hypotonia, hyperphagia, increased risk of morbid obesity and behavioral problems. Endocrine insufficiencies are common, although insufficient function of the hypothalamus-pituitary-adrenal (HPA) axis seems to be rare. The effect of long term exposure to cortisol, which is associated with stress and obesity, is unknown in PWS. Measurement o...

ea0056p749 | Neuroendocrinology | ECE2018

Latest safety outcomes from the PATRO adults study of omnitrope® for the treatment of adult patients with growth hormone deficiency

Beck-Peccoz Paolo , Hoybye Charlotte , Murray Robert , Simsek Suat , Zabransky Markus , Zouater Hichem , Stalla Gunter

Introduction: Omnitrope® (Sandoz) is a recombinant human growth hormone (rhGH) and was the first biosimilar medicine approved by the European Medicines Agency. PATRO Adults is an international, longitudinal, non-interventional study of the long-term safety and efficacy of Omnitrope® in adults treated in routine clinical practice. The study provides data on the long-term safety of rhGH in adult patients with severe GH deficiency (GHD). Here we pr...

ea0056p908 | Endocrine Nursing | ECE2018

Patient perspectives on sexuality in hypopituitarism

Bjorkman Ida , Persson Jenny Tiberg , Ung Eva Jakobsson , Olofsson Ann-Charlotte , Johannsson Gudmundur , Dellenborg Lisen

Aim: The aim of the study was to explore patient perspectives on sexuality in hypopituitarism.Background: Hypopituitarism usually leads to a complete loss of sex hormones and the condition has a negative impact on sexuality. Previous research has mainly focused on erectile functioning in men and fertility issues in women but little is known about their sexual wellbeing and experiences of hypopituitarism in relation to sexuality.Des...

ea0045oc6.1 | Oral Communications 6- Endocrine | BSPED2016

The intra- and inter-user reliability of testicular volume estimation – a simulation study

Akbarian-Tefaghi Ladan , De Silva Shamani , Langley Joseph , Stanton Andrew , Wright Neil , Elder Charlotte

Background: Measuring testicular volume (TV) by orchidometer is a standard method of pubertal staging in boys. A paucity of evidence exists as to its inter and intra-user reliability and the impact of clinicians’ gender, training and experience on the accuracy of measurements. Specifically engineered prosthetic models of different size testes were developed to investigate the reliability of TV estimation.Method: The study was conducted over the thre...

ea0045p36 | Diabetes | BSPED2016

A critical review of type 1 diabetes new patient education programme at a single tertiary centre

Uday Suma , Avann Charlotte , Barrett Timothy , Dias Renuka , Drummond Lesley , Kershaw Melanie , Krone Ruth

Introduction: Good patient education is the key to successful self-management of diabetes. In October 2013, we introduced a revised and extended ‘Newly Diagnosed Patient Education Programme’ involving 20 structured education sessions delivered by the multidisciplinary team.Aim: To assess the effect of the new patient education programme on HbA1c at the end of two years and compare this to a control group undergoing the old education programme.<...

ea0072p15 | (1) | UKINETS2020

Specialist dietetic input in the south wales NET clinic: Patient outcomes

Dowd Charlotte , Powell Catherine , Taylor Rebecca , Cook Kathryn , Blackhouse Jennifer , Khan MS

Background: Nutritional data in NETs is lacking. There are a range of gastrointestinal issues which can be related to the NET, treatment, surgical intervention, or pre-existing diseases1. Many of these can have nutritional consequences or be improved through altering diet with the support of a specialist dietitian.From October 2018, a gastrointestinal specialist dietitian joined the weekly clinic for 12 months. The aim of the service evaluatio...